1. Home
  2. BNTX vs FCNCA Comparison

BNTX vs FCNCA Comparison

Compare BNTX & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTX
  • FCNCA
  • Stock Information
  • Founded
  • BNTX 2008
  • FCNCA 1898
  • Country
  • BNTX Germany
  • FCNCA United States
  • Employees
  • BNTX N/A
  • FCNCA N/A
  • Industry
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • FCNCA Major Banks
  • Sector
  • BNTX Health Care
  • FCNCA Finance
  • Exchange
  • BNTX Nasdaq
  • FCNCA Nasdaq
  • Market Cap
  • BNTX 23.9B
  • FCNCA 25.4B
  • IPO Year
  • BNTX 2019
  • FCNCA N/A
  • Fundamental
  • Price
  • BNTX $102.02
  • FCNCA $1,779.26
  • Analyst Decision
  • BNTX Strong Buy
  • FCNCA Buy
  • Analyst Count
  • BNTX 17
  • FCNCA 9
  • Target Price
  • BNTX $145.88
  • FCNCA $2,414.89
  • AVG Volume (30 Days)
  • BNTX 1.4M
  • FCNCA 116.6K
  • Earning Date
  • BNTX 05-05-2025
  • FCNCA 04-24-2025
  • Dividend Yield
  • BNTX N/A
  • FCNCA 0.44%
  • EPS Growth
  • BNTX N/A
  • FCNCA N/A
  • EPS
  • BNTX N/A
  • FCNCA 175.01
  • Revenue
  • BNTX $2,848,224,455.00
  • FCNCA $9,093,000,000.00
  • Revenue This Year
  • BNTX N/A
  • FCNCA $1.13
  • Revenue Next Year
  • BNTX $9.21
  • FCNCA $2.30
  • P/E Ratio
  • BNTX N/A
  • FCNCA $10.20
  • Revenue Growth
  • BNTX N/A
  • FCNCA N/A
  • 52 Week Low
  • BNTX $76.53
  • FCNCA $1,473.62
  • 52 Week High
  • BNTX $131.49
  • FCNCA $2,412.93
  • Technical
  • Relative Strength Index (RSI)
  • BNTX 50.69
  • FCNCA 51.66
  • Support Level
  • BNTX $96.54
  • FCNCA $1,703.95
  • Resistance Level
  • BNTX $120.62
  • FCNCA $1,855.83
  • Average True Range (ATR)
  • BNTX 7.34
  • FCNCA 97.34
  • MACD
  • BNTX 2.37
  • FCNCA 22.41
  • Stochastic Oscillator
  • BNTX 52.82
  • FCNCA 78.95

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: